Conveners
Session 2: Vaccines
- Olivier Terrier
-
Beatrice Grasland (Ploufragan l France)9/14/26, 11:00 AMOral presentation
-
Mr Julian Volk (Institute of Immunology)9/14/26, 11:30 AMAntivirals and VaccinesOral presentation
Current influenza vaccines primarily induce strain-specific antibodies against the variable hemagglutinin (HA) head while eliciting limited T cell immunity, resulting in suboptimal protection against drifted and emerging zoonotic influenza viruses. We developed an Orf virus-based influenza vaccine (ORFV-Flu) combining chimeric HAs with conserved influenza T cell epitopes to induce coordinated...
Go to contribution page -
Giulia Saresini9/14/26, 11:50 AMAntivirals and VaccinesOral presentation
During viral infection, replication errors can generate defective viral genomes (DVGs) that may interfere with virus replication and reduce infectious virus concentration. Identifying DVGs responsible for these effects is important because of their potential as antiviral candidates. However, experimentally screening all candidates is time- and resource-intensive, creating a need for...
Go to contribution page -
Bianca Maria Nastri (Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, 80138, Italy.)9/14/26, 12:10 PMAntivirals and VaccinesOral presentation
Introduction Antimicrobial peptides are small components of the innate immune system with broad-spectrum antimicrobial activity and immunomodulatory properties. Oreochromicins, isolated from the gills of Nile tilapia (Oreochromis niloticus), have previously demonstrated antiviral activities in vitro. In this study, we investigated for the first time the antiviral activity of Oreoch-1 against...
Go to contribution page